banner2

Getting started
CAS 7775-41-9

CAS 7775-41-9 - China Factory, Suppliers, Manufacturers

CAS 7775-41-9, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Fmoc-Asp-OtBu CAS 129460-09-9 Assay ≥98.5% (HPLC)
Read More

Fmoc-Cys(Dpm)-OH CAS 247595-29-5 Assay ≥98.0% (HPLC)

Fmoc-D-Asn(Trt)-OH CAS 180570-71-2 Assay ≥99.0% (HPLC)

Fmoc-Cys(Mtt)-OH CAS 269067-38-1 Assay ≥98.0% (HPLC)

Fmoc-Dap-OH CAS 181954-34-7 Assay ≥98.0% (HPLC)

Fmoc-D-Arg(Pbf)-OH CAS 187618-60-6 Purity ≥98.5% (HPLC) Factory

Fmoc-D-Bpa-OH CAS 117666-97-4 Assay ≥99.0% (HPLC)

banner4

Top Selling Products

Related Blog
Reviews

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...

2022.11.18 01:07:18
2022.09.07 21:33:08
2022.06.08 07:09:55
2022.03.29 11:16:52
2022.01.25 08:31:55
2021.11.07 14:30:50

related search